| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 05/31/2006 | CN1780811A Diphenylethylene compounds and uses thereof |
| 05/31/2006 | CN1780810A Asymmetric-synthesis catalyst based on chiral broensted acid and method of asymmetric synthesis with the catalyst |
| 05/31/2006 | CN1780643A Antiviral phosphonate analogs |
| 05/31/2006 | CN1257910C Phosphorus-containing hydroquinone derivatives, process for their production, phosphorus-containing epoxy resins made by using the derivatives, flame-retardant resin compositions, sealing media and it |
| 05/31/2006 | CN1257909C Process for the recovery of N-phosphonomethylglycine |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053249 Immunoassay; detecting emission |
| 05/30/2006 | US7053240 Process for synthesizing disulfides |
| 05/30/2006 | US7053231 phosphate ester compounds and copper ions within resin plate; improved infrared light absorption and ultraviolet light absorption properties while maintaining low levels off visible light absorption |
| 05/30/2006 | US7053138 For thermoplastic, thermosetting resin; using phosphinic compound |
| 05/30/2006 | US7053114 A modulator controls the activity of protein kinases, tyrosine kinase; enzyme inhibitors; nontoxic, solubility, formulability, bioavailability; cancer, diabetes, hepatic cirrhosis, atherosclerosis, angiogenesis, autoimmune disease and renal disease |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | CA2251924C Fluorescent chelates as visual tissue specific imaging agents |
| 05/30/2006 | CA2251132C Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents |
| 05/30/2006 | CA2165971C Methylphosphonic acid ester, process for preparing the same and its use |
| 05/30/2006 | CA2161246C Fullerene derivatives, methods of preparing them and their use |
| 05/30/2006 | CA2065128C Process for the preparation of phosphorus-containing l-amino acids, their derivatives and intermediates for this process |
| 05/26/2006 | WO2006055879A2 Novel phosphorous containing steroid mimics |
| 05/26/2006 | WO2006055441A1 Recovery of noble metals from aqueous process streams in the synthesis of glyphosate using adsorption media such as ion exchange resins |
| 05/26/2006 | WO2006054466A1 Novel radioactive technetium/bisphosphinoamine complex and radioactive imaging diagnostic agent containing the complex |
| 05/26/2006 | WO2006054426A1 Hydrophobic fluorescent probe of high-fluorescent quantum efficiency type, and method of detecting biopolymer and method of detecting interaction between biopolymers by using the same |
| 05/26/2006 | WO2006054298A2 Glycogen synthase kinase-3 inhibitors |
| 05/26/2006 | WO2006053910A1 Biphosphonic compounds for preventing or limiting fixing of macromolecules, micro-organisms and biofilm on solid, in particular metal or mineral surfaces |
| 05/26/2006 | WO2006036743A3 Halocombstatins and methods of synthesis thereof |
| 05/26/2006 | WO2006000390A3 Compounds for organic electronic devices |
| 05/26/2006 | CA2588832A1 Biphosphonic compounds for preventing or limiting fixing of macromolecules, micro-organisms and biofilm on solid, in particular metal or mineral surfaces |
| 05/26/2006 | CA2587732A1 Glycogen synthase kinase-3 inhibitors |
| 05/26/2006 | CA2587384A1 Recovery of noble metals from aqueous process streams in the synthesis of glyphosate using adsorption media such as ion exchange resins |
| 05/26/2006 | CA2586363A1 Protein tyrosine phosphatase inhibitors and methods of use thereof |
| 05/26/2006 | CA2583409A1 Phospho-indoles as hiv inhibitors |
| 05/25/2006 | US20060111329 Anticancer Agents Based on Regulation of Protein Prenylation |
| 05/25/2006 | US20060111328 matrix metalloproteinases (MMPs) inhibitor; N-(1-cyclohexylethyl)carbamoylphosphonic acid; anticarcinlgenic, coronary atherosclerosis, rheumatoid arthritis, tumor invasion, metastasis, angiogenesis, multiple sclerosis, periodontal disease, restenosis, heart failure, osteoporosis, liver cirrhosis |
| 05/25/2006 | US20060111327 Derivatives of triptolide having a high immunosuppressive effect and high water solubility, and uses thereof |
| 05/25/2006 | US20060111326 sulfonamidophosphonate-functional heteroaryl compounds that contain SO2-NH-P(O)(-OR)2 group; antiinflammatory and analgesics; e.g. N-[4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]phenylsulfonyl]phosphoramidic acid; injectable COX-2 inhibitors |
| 05/25/2006 | US20060111325 Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
| 05/25/2006 | US20060111324 (+)-Ttrans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl)methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/25/2006 | US20060111276 Enhanced oral bioavailability and increased uptake of the compound by gastrointestinal tract membrane transporter |
| 05/25/2006 | US20060110638 Electrochromic compounds |
| 05/24/2006 | EP1659128A1 Novel optically active rare earth complex emitting circularly polarized light |
| 05/24/2006 | EP1658852A1 Oral pharmaceutical preparation containing ibandronat |
| 05/24/2006 | EP1658299A2 Method for the production of cyclic phosphonic acid anhydrides |
| 05/24/2006 | EP1658298A2 Novel organic compounds and metal complexes |
| 05/24/2006 | EP1658282A1 Novel chelating agents and chelates and their use |
| 05/24/2006 | EP1658264A2 Methods and compositions for treating amyloid-related diseases |
| 05/24/2006 | EP1658262A2 Method for producing ionic liquids, ionic solids or mixtures thereof |
| 05/24/2006 | EP1499587A4 Process for synthesizing pharmaceutically active disulfide salts |
| 05/24/2006 | EP1403272B1 Process for preparation of phosphoric esters |
| 05/24/2006 | EP1259520B1 Novel purines |
| 05/24/2006 | DE4338691B4 Haarbehandlungsmittel Hair treatment agent |
| 05/24/2006 | DE102004029812A1 Verfahren zur Herstellung von Nitrilen aus Aldehydoximen durch Umsetzung mit Alkylphosphonsäureanhydriden A process for the production of nitriles from Aldehydoximen by reaction with alkylphosphonic |
| 05/24/2006 | CN1777616A Method for producing acylphosphine oxide solids |
| 05/24/2006 | CN1777575A Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 05/24/2006 | CN1775786A Method for separating and concentrating glyphosate stock solution |
| 05/24/2006 | CN1775785A Methamidophos half-antigen, artificial antigen and its preparing method |
| 05/24/2006 | CN1257175C Adefovir dipivoxil new crystal state, new crystal state composition and its preparing method |
| 05/24/2006 | CN1257174C Producing process for N-[3-(tert-butyl oxycarbonyl amino) propy1]-2-amino ethylphosphonic acid diallcyl-ester |
| 05/24/2006 | CN1257173C Method for synthesis of 1-hydroxy-1,1-bis-phosphonic acids compounds |
| 05/24/2006 | CN1257172C Process for making glyphosate acid ammonium salt by catalyzing and oxidizing double gly phosphine under homogeneous phase |
| 05/24/2006 | CN1257169C Bicyclic imidazo-3-yl-amine derivatives |
| 05/24/2006 | CN1257166C Process for preparing tricyclic compound having antihistaminic activity |
| 05/23/2006 | US7049470 Bis (aminostyryl) anthracene compound, synthesis is intermediate thereof, and process for production thereof |
| 05/23/2006 | US7049463 Process for the preparation of highly purified, dialkyl phosphinic acids |
| 05/23/2006 | US7049456 Method for preparing O,O-dialkyl S-[2-(alkylthio)alkyl] phosphorodithioates |
| 05/23/2006 | US7049443 Such as 2-(3-(Acetyl(((5S)-3-(4-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-3 -fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)meth yl)amino)-1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl dihydrogen phosphate; improved bioavailability |
| 05/23/2006 | US7049441 Process for preparation of benzylpiperidine compounds |
| 05/23/2006 | US7049378 Polymerization of olefin |
| 05/23/2006 | US7049374 Heterodiamondoids |
| 05/23/2006 | US7049316 Prodrugs of CC-1065 analogs |
| 05/23/2006 | US7049073 Using phosphoramidite compound; biosynthesis |
| 05/23/2006 | CA2319780C Improved separation processes |
| 05/23/2006 | CA2301189C Non-steroidal ligands for the estrogen receptor |
| 05/23/2006 | CA2261619C Nucleotide analogs |
| 05/23/2006 | CA2152289C Process for preparing aromatic olefins using palladacycle catalysis |
| 05/18/2006 | WO2006052630A1 Therapeutic substituted piperidone compounds |
| 05/18/2006 | WO2006051810A1 Metal complex compounds and organic electroluminescent devices made by using the same |
| 05/18/2006 | WO2006014429A3 Cidofovir peptide conjugates as prodrugs |
| 05/18/2006 | US20060106259 Phospha-adamantane(s) catalytic system |
| 05/18/2006 | US20060106248 Recovery of noble metals from aqueous process streams |
| 05/18/2006 | US20060106247 Catalytic hydrogenation of carbon-heteroatom double bonds |
| 05/18/2006 | US20060106155 Phosphite reactions in the presence of metal soaps for liquid stabilisers |
| 05/18/2006 | US20060106069 4-(5-Chloro-2-isopropylaminopyridin-4-yl)-1-(toluene-4-sulfonyl)-1H-pyrrole-2-carboxylic acid methyl ester; mitogen-activated protein kinase inhibitor; antiproliferative, anticarcinogenic agent; study of intracellular signal transduction pathways; evaluation of new kinase inhibitors |
| 05/18/2006 | US20060106006 Including vanadocene dihalides, bis(methylcyclopentadienyl), vanadocene diazide, vanadocene dicyanide, vanadocene dioxycyanate, vanadocene dithiocyanate, vanadocene diselenocyanate, vanadocene ditriflate, vanadocene monochloro oxycyanate, vanadocene monochloro acetonitrilo tetrachloro ferrate |
| 05/18/2006 | US20060106001 chelates metals and metalloids in saline solution of blood; for dissolving artery plaque, as well as copper, zinc and iron; neurodegenerative disorders: Alzheimer's disease |
| 05/18/2006 | US20060105999 Novel inhibitors of beta-lactamase |
| 05/18/2006 | US20060105998 Antiprotozoal ring-substiuted phospholipids |
| 05/18/2006 | US20060105996 glycerophospholipids in which sugar alcohols have been incorporated into the phosphatidylcholine molecules; antiproliferative effect; do not interfere with DNA synthesis, or influence the cytoskeleton; low cytotoxic side effects |
| 05/18/2006 | US20060105994 Treatment of prostate cancer |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060102895 Precursor compositions for forming tantalum-containing films, and tantalum-containing barrier films and copper-metallized semiconductor device structures |
| 05/18/2006 | DE102004055284A1 Pharmaceutical composition containing phospholipid, sterol and negative charge carrier, useful in human or veterinary medicine for treating e.g. arthropod, protozoal and bacterial infections or tumors |
| 05/18/2006 | DE102004026799B4 Pressgranulierte Flammschutzmittelzusammensetzung, Verfahren zu deren Herstellung und deren Verwendung The compression-granulated flame retardant composition, process for their preparation and their use |
| 05/18/2006 | CA2590046A1 Process for preparing a pure polymorphic form of 3-pyridyl-1-hydroxyethylidine-1,1-bisphosphonic acid sodium salt |
| 05/18/2006 | CA2587103A1 Synthesis of cardiolipin analogues and uses thereof |
| 05/17/2006 | EP1657972A1 Phosphinate complexes of metals of the 2nd, 3rd, 12th and 13th groups and their use as flame proofing agents |
| 05/17/2006 | EP1657954A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 05/17/2006 | EP1657288A1 2-Hydroxy-3-alkoxypropyl sulfides, sulfones, and sulfoxides: new surface active agents |
| 05/17/2006 | EP1656395A1 Process for the preparation of a metalloorganic compound comprising at least one imine ligand |
| 05/17/2006 | EP1656387A2 Nucleobase phosphonate analogs for antiviral treatment |